EyePoint, Inc. (EYPT) SEC filings
EYPT SEC filings moved a median of -0.01% by the close. EYPT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the EYPT overview →
78 measured EYPT SEC filing events.
Where these EYPT SEC filings landedvs 76 measured EYPT SEC filing reactions
| Middle 50% of EYPT SEC filing reactions | -4.23% to +3.16% |
|---|---|
| Median reaction (to close) | -0.01% |
| Measured reactions | 76 |
Point-in-time · zero look-ahead
Half of the 76 EYPT SEC filing events with a measured close landed between -4.23% and +3.16%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K EyePoint, Inc. For: Sep 10 | SEC filing · Form 8-K | +0.23% | -1.62% | |
| Form 8-K EyePoint, Inc. For: Aug 17 | SEC filing · Form 8-K | +14.97% | +21.75% | |
| Form 10-Q EyePoint, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.94% | +4.74% | |
| Form 8-K EyePoint, Inc. For: Aug 05 | SEC filing · Form 8-K | +0.71% | +3.11% | |
| Form S-8 EyePoint, Inc. | SEC filing · Form S-8 | -0.94% | +4.74% | |
| Form 8-K EyePoint, Inc. For: Jul 30 | SEC filing · Form 8-K | -1.64% | +5.67% | |
| Form 8-K EyePoint, Inc. For: Jul 13 | SEC filing · Form 8-K | +3.20% | -4.60% | |
| Form 8-K EyePoint, Inc. For: Jun 18 | SEC filing · Form 8-K | +1.21% | +0.81% | |
| Form 8-K EyePoint, Inc. For: May 14 | SEC filing · Form 8-K | +0.19% | -1.05% | |
| Form 10-Q EyePoint, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.31% | +2.32% | |
| Form 8-K EyePoint, Inc. For: May 06 | SEC filing · Form 8-K | -0.80% | -2.77% | |
| Form DEF 14A EyePoint, Inc. For: Jun 18 | SEC filing · Form DEF | +2.31% | +0.22% | |
| Form DEFA14A EyePoint, Inc. | SEC filing · Form DEFA14A | +2.31% | +0.22% | |
| Form 8-K EyePoint, Inc. For: Apr 13 | SEC filing · Form 8-K | +1.31% | -1.24% | |
| Form 8-K EyePoint, Inc. For: Mar 20 | SEC filing · Form 8-K | +0.11% | -4.25% | |
| Form 10-K EyePoint, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.13% | +3.96% | |
| Form 8-K EyePoint, Inc. For: Mar 04 | SEC filing · Form 8-K | +0.55% | -0.83% | |
| Form 8-K EyePoint, Inc. For: Feb 26 | SEC filing · Form 8-K | +2.10% | +6.75% | |
| Form 8-K EyePoint, Inc. For: Jan 07 | SEC filing · Form 8-K | +1.44% | +0.29% | |
| Form 8-K EyePoint Pharmaceuticals For: Dec 08 | SEC filing · Form 8-K | -1.57% | -3.22% | |
| Form 8-K EyePoint Pharmaceuticals For: Nov 19 | SEC filing · Form 8-K | +1.56% | +3.48% | |
| Form 10-Q EyePoint Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.47% | +2.84% | |
| Form 8-K EyePoint Pharmaceuticals For: Nov 06 | SEC filing · Form 8-K | -1.47% | +2.84% | |
| Form 8-K EyePoint Pharmaceuticals For: Nov 05 | SEC filing · Form 8-K | -8.98% | -4.22% | |
| Form 8-K EyePoint Pharmaceuticals For: Oct 14 | SEC filing · Form 8-K | -0.22% | +2.29% | |
| Form 8-K EyePoint Pharmaceuticals For: Oct 14 | SEC filing · Form 8-K | -4.67% | -13.05% | |
| Form S-3ASR EyePoint Pharmaceuticals | SEC filing · Form S-3ASR | -4.67% | -13.05% | |
| Form 10-Q EyePoint Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.69% | +0.79% | |
| Form S-8 EyePoint Pharmaceuticals | SEC filing · Form S-8 | -0.69% | +0.79% | |
| Form 8-K EyePoint Pharmaceuticals For: Aug 06 | SEC filing · Form 8-K | -1.63% | +7.74% | |
| Form 8-K EyePoint Pharmaceuticals For: Jul 29 | SEC filing · Form 8-K | +0.25% | — | |
| Form 8-K/A EyePoint Pharmaceuticals For: Jul 29 | SEC filing · Form 8-K | -0.15% | — | |
| Form 8-K EyePoint Pharmaceuticals For: Jun 18 | SEC filing · Form 8-K | +0.77% | -7.06% | |
| Form 8-K EyePoint Pharmaceuticals For: May 27 | SEC filing · Form 8-K | -1.38% | +2.58% | |
| Form DEFA14A EyePoint Pharmaceuticals | SEC filing · Form DEFA14A | +0.66% | -4.75% | |
| Form 10-Q EyePoint Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.66% | -4.75% | |
| Form 8-K EyePoint Pharmaceuticals For: May 07 | SEC filing · Form 8-K | +0.64% | -2.56% | |
| Form DEF 14A EyePoint Pharmaceuticals For: Jun 18 | SEC filing · Form DEF | -0.74% | -1.19% | |
| Form DEFA14A EyePoint Pharmaceuticals | SEC filing · Form DEFA14A | -0.74% | -1.19% | |
| Form 10-K EyePoint Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.73% | +4.54% | |
| Form 8-K EyePoint Pharmaceuticals For: Mar 05 | SEC filing · Form 8-K | -0.16% | +5.45% | |
| Form 8-K EyePoint Pharmaceuticals For: Mar 04 | SEC filing · Form 8-K | +1.63% | +9.75% | |
| Form 8-K EyePoint Pharmaceuticals For: Feb 05 | SEC filing · Form 8-K | +11.67% | +18.18% | |
| Form 8-K EyePoint Pharmaceuticals For: Jan 13 | SEC filing · Form 8-K | -0.74% | -4.91% | |
| Form 8-K EyePoint Pharmaceuticals For: Jan 08 | SEC filing · Form 8-K | -2.28% | -0.98% | |
| Form 8-K EyePoint Pharmaceuticals For: Dec 04 | SEC filing · Form 8-K | +0.56% | +1.31% | |
| Form 10-Q EyePoint Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.26% | +0.34% | |
| Form 8-K EyePoint Pharmaceuticals For: Nov 07 | SEC filing · Form 8-K | -2.26% | -6.61% | |
| Form 8-K EyePoint Pharmaceuticals For: Oct 28 | SEC filing · Form 8-K | +4.46% | +1.51% | |
| Form 8-K EyePoint Pharmaceuticals For: Oct 28 | SEC filing · Form 8-K | -1.87% | +13.48% | |
| Form 8-K EyePoint Pharmaceuticals For: Oct 22 | SEC filing · Form 8-K | -2.87% | -5.35% | |
| Form 8-K EyePoint Pharmaceuticals For: Sep 03 | SEC filing · Form 8-K | +0.37% | +2.58% | |
| Form EFFECT EyePoint Pharmaceuticals | SEC filing · Form EFFECT | +0.88% | -0.25% | |
| Form 10-Q EyePoint Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.22% | -2.45% | |
| Form S-3 EyePoint Pharmaceuticals | SEC filing · Form S-3 | -0.22% | -2.45% | |
| Form S-8 EyePoint Pharmaceuticals | SEC filing · Form S-8 | -0.22% | -2.45% | |
| Form 8-K EyePoint Pharmaceuticals For: Aug 07 | SEC filing · Form 8-K | -1.73% | -6.59% | |
| Form 8-K EyePoint Pharmaceuticals For: Jun 26 | SEC filing · Form 8-K | +1.18% | -3.42% | |
| Form 8-K EyePoint Pharmaceuticals For: Jun 20 | SEC filing · Form 8-K | -0.24% | +3.29% | |
| Form 8-K EyePoint Pharmaceuticals For: May 28 | SEC filing · Form 8-K | +1.10% | +2.11% | |
| Form 10-Q EyePoint Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.29% | +6.61% | |
| Form 8-K EyePoint Pharmaceuticals For: May 08 | SEC filing · Form 8-K | -1.31% | -2.61% | |
| Form 8-K EyePoint Pharmaceuticals For: May 06 | SEC filing · Form 8-K | -3.78% | -19.37% | |
| Form DEF 14A EyePoint Pharmaceuticals For: Jun 20 | SEC filing · Form DEF | +0.00% | +5.76% | |
| Form DEFA14A EyePoint Pharmaceuticals | SEC filing · Form DEFA14A | +0.00% | +5.76% | |
| Form 10-K EyePoint Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.33% | +0.87% | |
| Form 8-K EyePoint Pharmaceuticals For: Mar 07 | SEC filing · Form 8-K | -0.87% | -4.13% | |
| Form 8-K EyePoint Pharmaceuticals For: Mar 04 | SEC filing · Form 8-K | +0.04% | -6.90% | |
| Form 8-K EyePoint Pharmaceuticals For: Jan 10 | SEC filing · Form 8-K | -0.91% | -7.63% | |
| Form 8-K EyePoint Pharmaceuticals For: Dec 05 | SEC filing · Form 8-K | +2.51% | -5.76% | |
| Form 8-K EyePoint Pharmaceuticals For: Dec 04 | SEC filing · Form 8-K | -3.77% | -16.64% | |
| Form 8-K EyePoint Pharmaceuticals For: Nov 09 | SEC filing · Form 8-K | -2.10% | -7.82% | |
| Form 10-Q EyePoint Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.19% | -0.83% | |
| Form 8-K EyePoint Pharmaceuticals For: Nov 01 | SEC filing · Form 8-K | -0.53% | +10.45% | |
| Form EFFECT EyePoint Pharmaceuticals | SEC filing · Form EFFECT | -1.38% | +3.44% | |
| Form S-3 EyePoint Pharmaceuticals | SEC filing · Form S-3 | -3.61% | -9.57% | |
| Form S-8 EyePoint Pharmaceuticals | SEC filing · Form S-8 | -3.61% | -9.57% | |
| Form 8-K EyePoint Pharmaceuticals For: Oct 13 | SEC filing · Form 8-K | +1.85% | +1.35% |
Keep exploring
More EYPT: earnings → · analyst actions → · EYPT overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Catalyst Pharmaceuticals, Inc. (CPRX) | 441 | 0.00% | 50% |
| Pacific Biosciences of California, Inc. (PACB) | 440 | -0.29% | 44% |
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.